Personalized Immunotherapeutic for Antibiotic-resistant Infection

计划入组 1 人 · 首次发布于 2015 年 7 月 27 日

UKK-0018 as an Immunotherapeutic for Treatment of Peanut Allergies

计划入组 40 人 · 首次发布于 2026 年 1 月 16 日

Prediction of Immunotherapeutic Effect of Advanced Non-small Cell Lung Cancer

计划入组 200 人 · 首次发布于 2020 年 6 月 11 日

IMT-1012 Immunotherapeutic vaccine

OXS-1850

antigen-specific immunotherapeutic vaccine

OSE IMMUNOTHERAPEUTICS

France

MoonLake Immunotherapeutics

Switzerland

RUTI Immunotherapeutics S.L.

Advancing Early-Phase Immunotherapeutic Trials: Optimizing Design and Patient Selection

HCW Biologics Reports Positive Preliminary Phase 1 Data for IL-2 Fusion Immunotherapeutic HCW9302 in Alopecia Areata

HCW Biologics Achieves 100% Survival Rate with Novel T-Cell Engagers in Pancreatic Cancer Preclinical Study